Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARHGEF17 antisense RNA 1 (ARHGEF17-AS1) is a human long non-coding antisense RNA transcript located at the ARHGEF17 gene locus. Like other antisense RNAs, its primary function is believed to involve regulating the expression of its sense counterpart (the ARHGEF17 gene) or nearby genes through various mechanisms, such as altering chromatin structure or modifying transcriptional or post-transcriptional events. ARHGEF17-AS1 does not encode a protein, and there is currently no evidence supporting its use as a direct therapeutic target or receptor. There is limited knowledge regarding its precise biological functions and disease associations; any functional effects are hypothesized based on general properties of antisense lncRNAs. There are no known drugs, biomarkers, or specific safety concerns related to ARHGEF17-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARHGEF17 antisense RNA 1 (ARHGEF17-AS1).